These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33238823)

  • 1. Provisional focal stenting of complex femoropopliteal lesions using the Multi-LOC multiple stent delivery system - 12-month results from the LOCOMOTIVE EXTENDED study.
    Amendt K; Zeller T; Proczka R; Beschorner U; Troisi N; Waliszewski M; Langhoff R; Krankenberg H; Hansch A; Krcmar T; Vidjak V; Nolte-Ernsting C; Hansen A; Sigl M
    Vasa; 2021 Apr; 50(3):209-216. PubMed ID: 33238823
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
    Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal Stenting of Complex Femoropopliteal Lesions with the Multi-LOC Multiple Stent Delivery System: 12-Month Results of the Multicenter LOCOMOTIVE Study.
    Sigl M; Beschorner U; Zeller T; Waliszewski M; Langhoff R; Tautenhahn J; Amendt K
    Cardiovasc Intervent Radiol; 2019 Feb; 42(2):169-175. PubMed ID: 30361959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical experience with the Multi-LOC multiple stent delivery system for focal stenting in long femoro-popliteal lesions.
    Amendt K; Beschorner U; Waliszewski M; Sigl M; Langhoff R; Thalwitzer J; Redlich U; Vogel B; Härtel D; Zeller T
    Vasa; 2017 Oct; 46(6):452-461. PubMed ID: 28854856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of the TIGRIS Vascular Stent Within a Modern Treatment Algorithm.
    Werner M; Gomari-Grisar F; Belalcazar S; Hirschl M; Kalchhauser G; Al-Taiee B; Jäger N; Westhausser C; Tischler M; Tischler R
    J Endovasc Ther; 2019 Oct; 26(5):637-642. PubMed ID: 31303096
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
    Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
    J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provisional Stenting Using the Zilver PTX Drug-Eluting Stent After Drug-Coated Balloon Angioplasty: Initial Experience From the Double Drug Dose "3D" Study.
    Fanelli F; Cannavale A; Citone M; Santoni M; Gazzetti M; Falcone GM; Miele V
    J Endovasc Ther; 2020 Feb; 27(1):34-41. PubMed ID: 31637956
    [No Abstract]   [Full Text] [Related]  

  • 11. Endovascular Treatment of Severely Calcified Femoropopliteal Lesions Using the "Pave-and-Crack" Technique: Technical Description and 12-Month Results.
    Dias-Neto M; Matschuck M; Bausback Y; Banning-Eichenseher U; Steiner S; Branzan D; Staab H; Varcoe RL; Scheinert D; Schmidt A
    J Endovasc Ther; 2018 Jun; 25(3):334-342. PubMed ID: 29557221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Safety and Effectiveness of Paclitaxel Drug-Coated Balloons Alone or With Provisional Bare Metal Stenting for Real-World Femoropopliteal Lesions: IN.PACT Global Study Subgroup Analysis.
    Ansel GM; Brodmann M; Rocha-Singh KJ; Menk JS; Zeller T;
    Circ Cardiovasc Interv; 2024 Feb; 17(2):e013084. PubMed ID: 38348677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
    Zeller T; Lopez L; Pigott JP
    J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Rocha-Singh KJ; Sachar R; DeRubertis BG; Nolte-Ernsting CCA; Winscott JG; Krishnan P; Scott EC; Garcia LA; Baeriswyl JL; Ansel G; Rosenfield K; Zeller T;
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):549-558. PubMed ID: 34080792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of Luminor™ balloon and Angiolite™ stent on TASC C/D tibial occlusive lesions in CLI patients: 12-month results. The MERLION trial.
    Tang TY; Yap CJ; Chan SL; Soon SX; Lee CT; Chong TT; Leong CR
    Int Angiol; 2021 Aug; 40(4):335-344. PubMed ID: 34056892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
    Owens CD; Gasper WJ; Walker JP; Alley HF; Conte MS; Grenon SM
    J Vasc Surg; 2014 Apr; 59(4):1016-24. PubMed ID: 24423476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of femoropopliteal atherosclerotic lesions using the ranger paclitaxel-coated balloon catheter: 12-month results from an all-comers registry.
    Lichtenberg M; von Bilderling P; Ranft J; Niemöller K; Grell H; Briner L; Saucy F; Rassaf T; Breuckmann F
    J Cardiovasc Surg (Torino); 2018 Feb; 59(1):45-50. PubMed ID: 28980462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.